Financhill
Back

Sinopharm Group 10K Form

Buy
68

SHTDY
Sinopharm Group

Last Price:
13.46
Seasonality Move:
-0.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SHTDY News And Ratings

See the #1 stock for the next 7 days that we like better than SHTDY

SHTDY Financial Statistics

Sales & Book Value

Annual Sales: $84.34B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0.8

Profitability

Net Income (TTM): $0
Gross Margin: $6.86B
Return on Equity: 0%
Return on Assets: 0%

Sinopharm Group Earnings Forecast

Key Sinopharm Group Financial Ratios

  • The Gross Profit Margin over the past 18 years for SHTDY is 8.13%.
  • The Selling, General & Administrative Expenses for SHTDY have been equal to 4.38% of Gross Profit Margin.
  • The Interest Expense is 32.66% of Operating Income.
  • The Net Earning history of SHTDY is 1.52% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 16 years.

Sinopharm Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: SHTDY
Website: sinopharmgroup.com.cn

Debt

Debt-to-Equity Ratio: 0.95
Current Ratio: 1.36
Quick Ratio: 0.98

Price-to-Earnings

Trailing P/E Ratio: 6.57
Forward P/E Ratio: 0

SHTDY Technical Analysis vs Fundamental Analysis

Buy
68
Sinopharm Group (SHTDY) is a Buy

Is Sinopharm Group a Buy or a Sell?

  • Sinopharm Group stock is rated a Buy
    The current Sinopharm Group [SHTDY] share price is $13.46. The Score for SHTDY is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.